What are the inclusion criteria for the Waagstein MDC Metoprolol Study?
The inclusion criteria for the Waagstein MDC Metoprolol Study are symptomatic dilated cardiomyopathy and ejection fraction below 35%, aged 16-75 years, and a state of compensated heart failure by means of conventional heart failure treatment, which could include digitalis, diuretics, ACEI and nitrates.